Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

41.89 +0.73 (+1.77%)

Streaming Delayed Price Updated: 1:56 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	317,355
Open	41.09
Bid (Size)	41.87 (200)
Ask (Size)	41.91 (300)
Prev. Close	41.16
Today's Range	40.64 - 42.08
52wk Range	26.74 - 44.23
Shares Outstanding	63,562,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Xenon to Present at Upcoming Investor Conferences

November 06, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

These stocks are moving in today's after hours session ↗

November 03, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Performance

YTD	+4.3%	+4.3%
1 Month	+2.8%	+2.8%
3 Month	+9.8%	+9.8%
6 Month	+42.2%	+42.2%
1 Year	+0.5%	+0.5%

More News

Xenon Reports Third Quarter 2025 Financial Results & Business Update

November 03, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

A Look Ahead: Xenon Pharmaceuticals's Earnings Forecast ↗

August 08, 2025

Via Benzinga

Insights into Xenon Pharmaceuticals's Upcoming Earnings ↗

October 31, 2025

Via Benzinga

Xenon to Report Q3 2025 Financial Results on November 3, 2025

October 27, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer

October 16, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 07, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain

September 25, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Design Therapeutics Appoints Justin Gover to Board of Directors

September 10, 2025

From Design Therapeutics, Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 29, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Reports Second Quarter 2025 Financial Results & Business Update

August 11, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon to Report Q2 2025 Financial Results on August 11, 2025

August 04, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit ↗

July 07, 2025

Via Stocktwits

Xenon Joins the Russell 3000® and Russell 2000® Indexes

June 27, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 26, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Announces Appointment of Darren Cline as Chief Commercial Officer

June 24, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

June 03, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 30, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Crude Oil Gains 3%; US Inflation Eases In April ↗

May 13, 2025

Via Benzinga

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025

From Xenon Pharmaceuticals Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?

Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.

What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?

Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?

The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market

What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?

The current price of Xenon Pharmaceuticals Inc. - Common Shares is 41.89

When was Xenon Pharmaceuticals Inc. - Common Shares last traded?

The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 11/24/25 01:56 PM ET

What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?

The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 2.66B

How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?

Xenon Pharmaceuticals Inc. - Common Shares has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.